Coloplast A/S

Coloplast A/S

CBHD · Deutsche Borse Xetra

Coloplast A/S (CBHD) is a Medical equipment services company in the Healthcare sector, listed on Deutsche Borse Xetra. This page provides the complete earnings calendar, dividend schedule, and financial data for Coloplast A/S in 2026. The next earnings report is expected on November 3, 2026.

Earnings calendar

Next earnings date

03 Nov 2026

In 74 days

EPS estimate

0.85

Revenue estimate

1.1B

Past earnings

18 Aug 2026
EPS actual
1.00 (+6.8%)
estimate 0.94
Revenue actual
1.1B (+1.5%)
estimate 1.1B
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
12 May 2026
EPS actual
0.95 (+4.3%)
estimate 0.91
Revenue actual
1.1B (+0.1%)
estimate 1.1B
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
06 Feb 2026
EPS actual
0.99 (+3.5%)
estimate 0.96
Revenue actual
1.1B (-1.3%)
estimate 1.1B
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Latest earnings analysis

Coloplast A/S beat consensus estimates in its latest earnings report, with EPS of USD 1.0014 coming in 6.8% above expectations and revenue of USD 1.12 billion exceeding estimates by 1.5%. In the previous quarter, EPS also beat expectations while revenue met estimates.

Dividend calendar

Next ex-dividend

—

Not scheduled

Next payment

—

Not scheduled

Dividend amount

—

Not available

Past dividends

Ex-dividend Payment Amount
18 May 2026 20 May 2026 0.78

EPS (Earnings Per Share)

Revenue

Dividend per share

Company profile

Coloplast A/S develops, manufactures, and markets medical products. The company is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature. Its operations are structured into four business areas: Ostomy Care offering products for people whose intestinal outlet has been rerouted through the abdominal wall, Continence Care products for people suffering from diseases of and damage to the urinary system, Urology Care products for people suffering from diseases of and damage to the kidneys, the urinary system or the male reproductive system and Wound & Skin Care for the treatment of chronic wounds and skin care products for prevention and treatment. The firm supplies products to hospitals, institutions as well as wholesalers and pharmacies.

Sector
Healthcare
Industry
Medical equipment services
Country
Denmark
Exchange
Deutsche Borse Xetra
CEO
Lars Soren Rasmussen
Employees
16,741
IPO date
24 Jan 2007
ISIN
DK0060448595
Website
coloplast.dk

Frequently asked questions

When does Coloplast A/S (CBHD) next report earnings?

Coloplast A/S (CBHD) is scheduled to report earnings on November 3, 2026.

What was Coloplast A/S's most recent earnings date?

Coloplast A/S (CBHD) last reported earnings on August 18, 2026.

Where is Coloplast A/S stock listed?

Coloplast A/S (CBHD) is listed on Deutsche Borse Xetra.